Literature DB >> 25855484

Transition considerations for extended half-life factor products.

S E Croteau1, E J Neufeld1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25855484     DOI： 10.1111/hae.12683

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  3 in total

Review 1.  The role of patient and healthcare professionals in the era of new hemophilia treatments in developed and developing countries.

Authors:  Fadi Nossair; Courtney D Thornburg
Journal:  Ther Adv Hematol       Date:  2018-07-02

Review 2.  Current Clinical Applications of In Vivo Gene Therapy with AAVs.

Authors:  Jerry R Mendell; Samiah A Al-Zaidy; Louise R Rodino-Klapac; Kimberly Goodspeed; Steven J Gray; Christine N Kay; Sanford L Boye; Shannon E Boye; Lindsey A George; Stephanie Salabarria; Manuela Corti; Barry J Byrne; Jacques P Tremblay
Journal:  Mol Ther       Date:  2020-12-10       Impact factor: 11.454

3.  Focusing in on use of pharmacokinetic profiles in routine hemophilia care.

Authors:  Stacy E Croteau; Michael U Callaghan; Joanna Davis; Amy L Dunn; Michael Guerrera; Osman Khan; Ellis J Neufeld; Leslie J Raffini; Michael Recht; Michael Wang; Alfonso Iorio
Journal:  Res Pract Thromb Haemost       Date:  2018-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.